AI-generated summary
The authors describe a single case of a 61-year-old man with refractory multiple myeloma who developed taste loss after talquetamab and was treated with photobiomodulation. The authors report significant improvement in salty and bitter taste sensitivity after three sessions, with partial persistence of salty taste loss at seven weeks. As a single case report, the findings cannot establish a general effect.
- Who or what was studied
- A 61-year-old man with triple-class exposed relapsed or refractory multiple myeloma who developed talquetamab-related dysgeusia
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- The report describes a single patient, and the abstract gives no control group or comparison of outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 808 nm
- Energy density (fluence)
- 25 J/cm2
- Power
- 100 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Irradiance, Beam area, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.